Latest News and Press Releases
Want to stay updated on the latest news?
-
Standard Premium Reports Record-Breaking First Quarter Results, Driven by a 21% Increase in Earnings, 22% Return on Equity and Expanded National Footprint
-
New York, NY, May 12, 2026 (GLOBE NEWSWIRE) -- South Street Securities Holdings Inc. (“South Street”) today announced that it acquired 100% of the outstanding equity in Lime Funding, LLC (“Lime...
-
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary -- Investor interest in the next-generation wellness market is picking up fast as peptide-based health and performance...
-
Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility...
-
LAS VEGAS, May 12, 2026 (GLOBE NEWSWIRE) -- TON Strategy Company (“TON Strategy” or the “Company”) (Nasdaq: TONX), a digital asset treasury company dedicated to holding Toncoin ($TON), today...
-
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- GraniteShares, an independent ETF issuer and pioneer in high-conviction exchange-traded products, today announced the launch of the GraniteShares...
-
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression on track for Q2 2026VLS-01 Phase 2 Elumina topline results anticipated in Q4 2026Consistent, convergent improvements...
-
New integrated workflow enables more frequent, transparent, and scalable valuations NORWALK, Conn., May 12, 2026 (GLOBE NEWSWIRE) -- FactSet, a global financial digital platform and enterprise...
-
IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancer Enrollment...
-
Reached broad alignment with the FDA on the registration path for CRB-701 for 2L treatment in head and neck squamous cell carcinoma (HNSCC) and cervical cancer with CRB-701Announced presentation of...